JP2022521432A5 - - Google Patents

Info

Publication number
JP2022521432A5
JP2022521432A5 JP2021549631A JP2021549631A JP2022521432A5 JP 2022521432 A5 JP2022521432 A5 JP 2022521432A5 JP 2021549631 A JP2021549631 A JP 2021549631A JP 2021549631 A JP2021549631 A JP 2021549631A JP 2022521432 A5 JP2022521432 A5 JP 2022521432A5
Authority
JP
Japan
Prior art keywords
nucleic acid
recognition helix
dna
seq
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549631A
Other languages
English (en)
Japanese (ja)
Other versions
JP7624728B2 (ja
JP2022521432A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019546 external-priority patent/WO2020176426A1/en
Publication of JP2022521432A publication Critical patent/JP2022521432A/ja
Publication of JP2022521432A5 publication Critical patent/JP2022521432A5/ja
Priority to JP2024184019A priority Critical patent/JP2025003531A/ja
Application granted granted Critical
Publication of JP7624728B2 publication Critical patent/JP7624728B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549631A 2019-02-25 2020-02-24 Dna結合ドメイントランスアクチベーター及びその使用 Active JP7624728B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024184019A JP2025003531A (ja) 2019-02-25 2024-10-18 Dna結合ドメイントランスアクチベーター及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962810005P 2019-02-25 2019-02-25
US62/810,005 2019-02-25
PCT/US2020/019546 WO2020176426A1 (en) 2019-02-25 2020-02-24 Dna-binding domain transactivators and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024184019A Division JP2025003531A (ja) 2019-02-25 2024-10-18 Dna結合ドメイントランスアクチベーター及びその使用

Publications (3)

Publication Number Publication Date
JP2022521432A JP2022521432A (ja) 2022-04-07
JP2022521432A5 true JP2022521432A5 (cg-RX-API-DMAC7.html) 2023-03-03
JP7624728B2 JP7624728B2 (ja) 2025-01-31

Family

ID=72238705

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549631A Active JP7624728B2 (ja) 2019-02-25 2020-02-24 Dna結合ドメイントランスアクチベーター及びその使用
JP2024184019A Pending JP2025003531A (ja) 2019-02-25 2024-10-18 Dna結合ドメイントランスアクチベーター及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024184019A Pending JP2025003531A (ja) 2019-02-25 2024-10-18 Dna結合ドメイントランスアクチベーター及びその使用

Country Status (14)

Country Link
US (1) US12583902B2 (cg-RX-API-DMAC7.html)
EP (1) EP3931213A4 (cg-RX-API-DMAC7.html)
JP (2) JP7624728B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210132109A (cg-RX-API-DMAC7.html)
CN (1) CN113710693B (cg-RX-API-DMAC7.html)
AU (2) AU2020228028A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021016294A2 (cg-RX-API-DMAC7.html)
CA (1) CA3129757A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021002226A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021011722A2 (cg-RX-API-DMAC7.html)
IL (1) IL285687A (cg-RX-API-DMAC7.html)
MX (1) MX2021010169A (cg-RX-API-DMAC7.html)
SG (1) SG11202108568YA (cg-RX-API-DMAC7.html)
WO (1) WO2020176426A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113710693B (zh) 2019-02-25 2025-07-15 马萨诸塞大学 Dna结合结构域反式激活因子及其用途
EP4185303A4 (en) * 2020-07-24 2024-10-30 University of Massachusetts Dna-binding domain transactivators and uses thereof
JP2024534410A (ja) * 2021-09-16 2024-09-20 ノバルティス アーゲー 新規転写因子
AU2022425534A1 (en) * 2021-12-30 2024-07-04 Regel Therapeutics, Inc. Compositions for modulating expression of sodium voltage-gated channel alpha subunit 1 and uses thereof
KR20250016657A (ko) * 2023-07-21 2025-02-04 한국화학연구원 dxCas9 및 CRP 유도체를 포함하는, 표적 유전자 발현 조절 시스템 및 이의 제조방법

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549910A (en) 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
US5252334A (en) 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JP3218637B2 (ja) 1990-07-26 2001-10-15 大正製薬株式会社 安定なリポソーム水懸濁液
JP2958076B2 (ja) 1990-08-27 1999-10-06 株式会社ビタミン研究所 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5741516A (en) 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5697899A (en) 1995-02-07 1997-12-16 Gensia Feedback controlled drug delivery system
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US5738868A (en) 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
US5656016A (en) 1996-03-18 1997-08-12 Abbott Laboratories Sonophoretic drug delivery system
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5783208A (en) 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5779708A (en) 1996-08-15 1998-07-14 Cyberdent, Inc. Intraosseous drug delivery device and method
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US6177403B1 (en) 1996-10-21 2001-01-23 The Trustees Of The University Of Pennsylvania Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
US6794136B1 (en) * 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US20030082561A1 (en) 2000-07-21 2003-05-01 Takashi Sera Zinc finger domain recognition code and uses thereof
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
CN1836048A (zh) 2003-06-10 2006-09-20 图尔金株式会社 可转导的dna结合蛋白
WO2007061759A1 (en) 2005-11-18 2007-05-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Delayed expression vectors
WO2011008260A2 (en) 2009-07-13 2011-01-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
US9567573B2 (en) 2010-04-26 2017-02-14 Sangamo Biosciences, Inc. Genome editing of a Rosa locus using nucleases
US10501512B2 (en) * 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
EP3169776B1 (en) * 2014-07-14 2025-09-03 The Regents of The University of California Crispr/cas transcriptional modulation
EP4600366A3 (en) 2015-03-31 2025-10-22 SOHM, Inc. Cas 9 retroviral integrase systems for targeted incorporation of a dna sequence into a genome of a cell
DK3352776T3 (da) 2015-09-23 2025-06-23 Sangamo Therapeutics Inc Htt-repressorer og deres anvendelse
WO2017053729A1 (en) 2015-09-25 2017-03-30 The Board Of Trustees Of The Leland Stanford Junior University Nuclease-mediated genome editing of primary cells and enrichment thereof
GB201517227D0 (en) 2015-09-29 2015-11-11 Univ Edinburgh Genetically-edited swine
WO2017070632A2 (en) * 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
GB2544270A (en) 2015-11-05 2017-05-17 Fundació Centre De Regulació Genòmica Nucleic acids, peptides and methods
EP3443081A4 (en) 2016-04-13 2019-10-30 Duke University CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE
JP7256739B2 (ja) 2016-09-07 2023-04-12 サンガモ セラピューティクス, インコーポレイテッド 肝臓遺伝子のモジュレーション
WO2018049075A1 (en) 2016-09-07 2018-03-15 Flagship Pioneering, Inc. Methods and compositions for modulating gene expression
JP2018088888A (ja) * 2016-12-06 2018-06-14 国立研究開発法人理化学研究所 Scn1a遺伝子の発現増強法
EP3579858A4 (en) 2017-02-07 2020-12-23 The Regents of The University of California GENE THERAPY AGAINST HAPLOINSUFFICIENCY
CN117821509A (zh) 2017-04-03 2024-04-05 编码治疗公司 组织选择性转基因表达
CN118345115A (zh) 2017-12-01 2024-07-16 编码治疗公司 工程化的dna结合蛋白
EP3781174A4 (en) 2018-04-09 2022-01-26 Allen Institute RESCUE OF VOLTAGE CONTROLLED SODIUM CHANNEL FUNCTION IN INHIBITORY NEURONS
WO2019224864A1 (ja) 2018-05-21 2019-11-28 国立研究開発法人理化学研究所 Scn1a遺伝子の発現増強法とそれによるドラベ症候群の治療法
JP7590962B2 (ja) 2018-11-05 2024-11-27 アレン インスティテュート 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
CN113710693B (zh) 2019-02-25 2025-07-15 马萨诸塞大学 Dna结合结构域反式激活因子及其用途
SG11202113048SA (en) 2019-05-29 2021-12-30 Encoded Therapeutics Inc Compositions and methods for selective gene regulation
EP4185303A4 (en) 2020-07-24 2024-10-30 University of Massachusetts Dna-binding domain transactivators and uses thereof

Similar Documents

Publication Publication Date Title
JP2021505133A5 (cg-RX-API-DMAC7.html)
JP2022535749A5 (cg-RX-API-DMAC7.html)
JP2024099770A5 (cg-RX-API-DMAC7.html)
ES2768763T3 (es) Vectores rAAV mejorados y métodos para la transducción de fotorreceptores y células EPR
CN106459932B (zh) 高胆红素血症的治疗
JP2023518541A5 (cg-RX-API-DMAC7.html)
JP2022511348A (ja) Aavトリプルプラスミドシステム
JP2020048571A5 (cg-RX-API-DMAC7.html)
FI3684423T3 (fi) Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä
IL299325B2 (en) Acid-alpha glucosidase variants and uses thereof
JP2022529631A5 (cg-RX-API-DMAC7.html)
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
US20230049066A1 (en) Novel aav3b variants that target human hepatocytes in the liver of humanized mice
JP2021512649A5 (cg-RX-API-DMAC7.html)
CN115996759A (zh) 合成aav衣壳用于肌肉和中枢神经系统障碍的基因治疗的用途
JP2023088902A5 (cg-RX-API-DMAC7.html)
HUE031182T2 (en) Gene therapy for spinal muscle atrophy
JP2023535025A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023537980A5 (cg-RX-API-DMAC7.html)
JP2021520811A5 (cg-RX-API-DMAC7.html)
JP2023059858A5 (cg-RX-API-DMAC7.html)
WO2021081280A1 (en) Adeno-associated virus vectors based gene therapy for hereditary angioedema
JP2025518052A5 (cg-RX-API-DMAC7.html)